Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1997-04-10
2000-09-12
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
5147723, A61F 228, A61K 4730
Patent
active
061174440
ABSTRACT:
A resorbable hemostatic agent comprising a delivery component, that aids in the delivery to the wound site, and a microfibrillar hemostatic component that controls bleeding in solid tissue and does not delay or interfere with healing is described. The viscosity of this resorbable hemostatic agent can be changed to allow for easy application at a range of temperatures. The resorbable hemostatic agent of the invention provides a biodegradable, biocompatable hemostatic agent which effectively controls bleeding in bone and other dense tissue without interfering with the subsequent healing of the tissue.
REFERENCES:
patent: 2772999 (1956-12-01), Masci et al.
patent: 2793976 (1957-05-01), McKinney
patent: 3742955 (1973-07-01), Battista et al.
patent: 4186448 (1980-02-01), Brekke
patent: 4291013 (1981-09-01), Wahlig et al.
patent: 4439420 (1984-03-01), Mattei et al.
patent: 4440789 (1984-04-01), Mattei et al.
patent: 4443430 (1984-04-01), Mattei et al.
patent: 4515637 (1985-05-01), Cioca
patent: 4806621 (1989-02-01), Kohn et al.
patent: 4863974 (1989-09-01), Mallouk et al.
patent: 4913903 (1990-04-01), Sudmann et al.
patent: 4983585 (1991-01-01), Pennell et al.
patent: 5156839 (1992-10-01), Pennell et al.
patent: 5324519 (1994-06-01), Dunn et al.
patent: 5464471 (1995-11-01), Whalen et al.
patent: 5595735 (1997-01-01), Saferstein et al.
patent: 5595751 (1997-01-01), Bezwada et al.
Baldauf, R., et al. (1986) "The Use of Bone Wax", J. Foot Surg., 25(6):456-458.
Blanche, C., et al. (1988) "The Use of Absorbable Microfibrillation Collagen to Control Sternal Bone Marrow Bleeding", Int. Surg., 73:42-43.
Finn, M. et al. (1992) "Osseous Regeneration in the Presence of Four Common Hemostatic Agents", J. Oral Maxillofac Surg., 50:608-612.
Friedman, R. et al. (1996) "Saline Made Viscous with Polyethylene Glycol: A New Alternate Breast Implant Filler Material", Plastic & Reconctructive Surg. 98(7):1208-1213.
Geary, J. et al. (1950) "New Absorbable Hemostatic Bone Wax," Annals of Surg., 132:1128-1137.
Harris, P. et al. (1980) "Clinical Experiance in Neurosurgery with Absele," Surg. Neurol. 13:231-235.
Harris, W. et al. (1978) "Topical Hemostatic Agents for Bone Bleeding in Humans," J. Bone & Joint Surg., 60A(4):454-456.
Kondell, P., et al. (1988) "Absele.RTM. in Bone Hemostasis--a clinical and experimental Investigation," Swed. Dent. J., 12:85-90.
Sohleim, E. et al. (1991) "Effect of Local Hemostatics on Platelet Aggregation," Eur. Surg. Res., 23:45-50.
Zirna, H. et al. (1987) "Topical Hemostatic Agents to Reduce Bleeding from Cancellous Bone Surfaces: A Comparision of Gelfoam Paste and Bone Wax," J. Foot Surg., 26(6):496-500.
Ehret Frederick W.
Mulliken John
Orgill Dennis P.
Azpuru Carlos A.
Brigham & Women's Hospital
DeConti, Esq. Giulio A.
LandOfFree
Polyethylene glycol/microfibrillar collagen composite serves as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyethylene glycol/microfibrillar collagen composite serves as , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyethylene glycol/microfibrillar collagen composite serves as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-93244